Parth Patel, PharmD

Experience

• 

  Walgreens

  May 2013 - Aug 2013

  Sales Representative

  Performed cost-benefit analyses of existing and potential customers. Maintained positive business relationships to ensure future sales.

• 

  Walmart

  Sept 2016 - Jul 2022

  Pharmacist

  • Managed end-to-end pharmacy operations, ensuring regulatory compliance, inventory control, and patient safety. • Counseled patients on medication adherence and disease management, improving clinical outcomes.

• 

  Eli Lilly and Company

  Jul 2020 - Aug 2020

  Pharmacy MSL Intern

  Produce deliverables for MSL team to present to key opinion leaders.Presented information about competitor drugs and keep team updated on two Lilly medications

• 

  Richard L Roudebush VA Medical Center / Health Services Research & Development

  Jun 2021 - Jul 2022

  Health Systems Research Fellow

  • Investigated and implemented process improvements in pharmacy workflow, enhancing patient safety and access. • Led research on post-COVID adaptations in the VA health system, identifying best practices for sustained improvements in patient care delivery.

• 

  Eli Lilly and Company

  Jun 2022 - now

  • Developed and globalized launch tactics for Wave 2 markets: UAE, Italy, Spain, France, Brazil, Canada, and Australia, creating an implementation guide to support successful regional execution. • Partnered closely with Lilly Marketing Studios to adapt and localize tactics, ensuring market-specific readiness, alignment, and pull-through. • Collaborated with the external agency of record (AOR) and vendors to update the belief bridge for an evolving disease state, refining messaging to resonate across diverse global audiences. Show less • Developed and implemented non-personal promotion (NPP) strategy targeting healthcare organizations (HCOs), with a primary focus on population health decision makers (PHDMs) and pharmacists. • Established a new NPP capability for Eli Lilly to strengthen outreach and engagement for key stakeholders in the healthcare system. • Launched an NPP email campaign delivering key messages to the target audience, achieving an open rate exceeding 50% and a click-through rate (CTR) over 4%. • Directed initiatives for three Tier 1 brands—Zepbound, Donanemab, and Mounjaro, ensuring targeted messaging and effective reach within the healthcare network. • Partnered with CMI (media agency) and the internal media excellence team to create an omnichannel approach to success in media planning, segmentation, and targeting. Show less • Created comprehensive Foundational Documents for both retatrutide (RET) and orforglipron (OFG) across potential disease indications—chronic weight management (CWM), osteoarthritis (OA), obstructive sleep apnea (OSA), and type 2 diabetes mellitus (T2DM)—to support strategic initiatives and streamline new team member onboarding.• Conducted an in-depth analysis of real-world dosing regimens, delivering actionable insights to optimize treatment protocols and enhance patient outcomes.• Performed a market analysis of emerging disease areas, identifying new opportunities for strategic growth and innovation within the therapeutic landscape.• Executed a detailed literature review of novel side effects associated with treatments for specific disease states, contributing to improved patient safety and treatment efficacy.• Led business planning for both RET and OFG, securing funding for the global team to gather critical insights and prepare for the upcoming molecule launches. Show less • Developed over 40 scientifically accurate and strategically aligned disclosures for Lebrikizumab, ensuring impactful communication of key findings and research insights.• Project managed and led cross-functional teams in medical affairs, medical development, statistics, and external thought leader authoring, fostering collaboration and maintaining alignment across stakeholders. • Assisted in updating standard operating procedures (SOPs) and protocols to enhance workflow efficiency and optimize team productivity. Show less

  • Manager – Global Marketing Alzheimer’s Therapeutics, Kisunla

    Apr 2024 - now

  • Manager – Lilly Value and Access, Health Care Organization Center of Excellence

    Oct 2023 - Apr 2024

  • Manager – Cardiometabolic Health, New Product Planning

    Apr 2023 - Oct 2023

  • Manager – Global Scientific Communication Publications

    Jun 2022 - Apr 2023